P/E at 59.54 vs Industry's 65.90: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Discount Amid Sector Premiums

The hospital sector currently commands a relatively elevated valuation, with an industry P/E of 65.90 reflecting investor optimism about growth prospects and sector resilience. Against this backdrop, Apollo Hospitals Enterprise Ltd.’s P/E of 59.54 suggests a modest discount, which could indicate either a more conservative market view on its near-term earnings growth or a reflection of recent operational challenges. This valuation gap of nearly 6.4 points is significant in a sector where premium multiples are often justified by robust earnings visibility and steady cash flows. Apollo Hospitals Enterprise Ltd.’s discount raises the question of whether this is a temporary divergence or a signal of deeper valuation recalibration — what is the current rating?

Performance Across Timeframes: Mixed Momentum Signals

Examining returns across multiple horizons reveals a complex momentum profile. Over the past year, Apollo Hospitals Enterprise Ltd. has delivered a 10.94% gain, outperforming the Sensex’s 10.03% loss over the same period. This outperformance extends to longer horizons, with three-year returns at 71.70% versus the Sensex’s 9.68%, five-year returns at 78.28% against 26.07%, and a remarkable ten-year return of 569.46% compared to the Sensex’s 160.16%. Such sustained outperformance underscores the company’s long-term growth credentials and sector leadership.

However, the short-term picture is less favourable. The stock has underperformed the Sensex over the past week (-1.48% vs -0.67%) and month (-1.38% vs -4.28%), though it has outpaced the benchmark over the last three months with a 3.69% gain compared to the Sensex’s 3.57% decline. Year-to-date, the stock’s 24.15% return is particularly strong against the Sensex’s 12.69% loss. This divergence between short-term weakness and medium-term strength suggests a period of consolidation or profit-taking within a broader uptrend. The 0.35% gain on the most recent trading day, despite underperforming the sector by 1.34%, adds to this nuanced momentum narrative — is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Moving Average Configuration: Mixed Technical Signals

The technical setup for Apollo Hospitals Enterprise Ltd. reveals a nuanced picture. The stock currently trades above its 100-day and 200-day moving averages, signalling that the longer-term trend remains intact and positive. However, it is positioned below the 5-day, 20-day, and 50-day moving averages, indicating recent short-term weakness or consolidation. This configuration often suggests a temporary pullback within a broader uptrend rather than a sustained breakdown. The interplay between these moving averages highlights a stock that may be undergoing a pause or correction phase, which is consistent with the mixed short-term performance data. is this a recovery or a dead-cat bounce?

Sector Context: Hospital Industry Performance

The hospital sector has experienced a varied performance landscape recently, with a mix of positive, flat, and negative results across constituent stocks. The sector’s elevated P/E ratio of 65.90 reflects investor confidence in healthcare demand resilience and structural growth drivers. Within this environment, Apollo Hospitals Enterprise Ltd.’s valuation discount and mixed momentum stand out. The sector’s performance has been buoyed by strong earnings growth in some peers, while others have faced margin pressures and regulatory challenges. This divergence within the sector underscores the importance of analysing individual stock data rather than relying solely on sector trends.

Rating Context: Previously Strong Buy, Now Reassessed

MarketsMOJO previously rated Apollo Hospitals Enterprise Ltd. as Strong Buy, with a Mojo Score of 77.0. The rating was updated on 15 Sep 2026, reflecting the latest data and market conditions. While the current rating is not disclosed, the reassessment acknowledges the evolving valuation and performance dynamics. The stock’s sustained outperformance over multiple years contrasts with recent short-term consolidation, presenting a complex picture for investors. Should investors in Apollo Hospitals hold, buy more, or reconsider?

Conclusion: A Valuation-Performance Balance in Flux

The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a meaningful discount to its sector’s lofty valuation multiples. Its long-term performance remains robust, with returns well above the Sensex across one, three, five, and ten-year periods. Yet, recent short-term momentum and technical indicators suggest a phase of consolidation or correction within a broader uptrend. The moving average configuration supports this interpretation, showing strength over longer horizons but caution in the near term. The reassessment of its rating from Strong Buy to a new status reflects these evolving dynamics. Investors analysing this stock must weigh the valuation discount against the mixed momentum signals — what is the current rating?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →